Shopping Cart
- Remove All
- Your shopping cart is currently empty
BIBO3304 TFA is an effective, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist (IC50:0.38 and 0.72 nM for the human and the rat Y1 receptor).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $98 | In Stock | |
2 mg | $148 | In Stock | |
5 mg | $233 | In Stock | |
10 mg | $412 | In Stock | |
25 mg | $686 | In Stock | |
50 mg | $977 | In Stock | |
100 mg | $1,320 | In Stock | |
1 mL x 10 mM (in DMSO) | $348 | In Stock |
Description | BIBO3304 TFA is an effective, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist (IC50:0.38 and 0.72 nM for the human and the rat Y1 receptor). |
Targets&IC50 | NPYY1 receptor:0.38 nM(human), NPYY1 receptor:0.72 nM (rat) |
In vivo | BIBO3304 TFA (15-60 μg) dose-dependently inhibits the feeding response mediated by 1 μg NPY. BIBO3304 TFA (30 μg; bilateral paraventricular nucleus injection) attenuates the hyperphagia following fasting [1]. BIBO3304 TFA (0.5?μM; p.o.) significantly increases serum insulin levels [2]. |
Molecular Weight | 643.66 |
Formula | C31H36F3N7O5 |
Cas No. | 191868-14-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (155.36 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.